Casey Kopczynski - Chief Scientific Officer and Founder - Aerie Pharmaceuticals, Inc | LinkedIn
Aerie Pharma: Latest News | Tracxn
Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals
Déjà vu: Aerie Announces Mercury 2 Results, Stock Jumps - Ophthalmology Innovation Summit - OIS
Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals
Aerie Pharma slips after announcing eye disease trial failed to meet primary endpoints | Seeking Alpha
Aerie Pharma leaps on positive Ph III efficacy results for Rhopressa
Aerie Pharma (AERI) Announces Positive Phase 3 Topline Results for Netarsudil Ophthalmic Solution 0.02% Clinical Trial in Japan
Working at Aerie Pharmaceuticals | Glassdoor
Aerie Pharma on go with mid-stage study of eye drop for dry eye (NASDAQ:AERI) | Seeking Alpha
Aerie Pharmaceuticals | WRAL TechWire
Aerie Pharmaceuticals and Ramot at Tel Aviv University Enter Research Collaboration | Business Wire
Aerie Pharmaceuticals Inc 2021 Current Report 8-K
Aerie Pharmaceuticals Employees, Location, Careers | LinkedIn
Aerie Pharma Reports Mixed Bag On Phase 2 Dry Eye Trial
Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals
Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals
Aerie Pharma Re-Ups In Irvine, CEO Departs | Orange County Business Journal
Global Ophthalmic Pipeline | Aerie Pharmaceuticals, Inc.
AERIE PHARMACEUTICALS, INC. - Aerie Pharmaceuticals, Inc. Trademark Registration
Aerie Pharmaceuticals Inc (AERI): Are Hedge Funds Right About This Stock?
